Literature DB >> 25821979

Correction: transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutatmatergic- and insulin-mediated neuronal processes.

.   

Abstract

Entities:  

Year:  2015        PMID: 25821979      PMCID: PMC4379046          DOI: 10.1371/journal.pone.0123269

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
There is an error in the title of this paper: “Glutatmatergic” should be “Glutamatergic.” The correct title is: Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutamatergic- and Insulin-Mediated Neuronal Processes. The correct citation is: Tamási V, Petschner P, Adori C, Kirilly E, Ando RD, Tothfalusi L, et al. (2014) Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutamatergic- and Insulin-Mediated Neuronal Processes. PLoS ONE 9(11): e113662. doi:10.1371/journal.pone.0113662
  1 in total

1.  Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes.

Authors:  Viola Tamási; Peter Petschner; Csaba Adori; Eszter Kirilly; Romeo D Ando; Laszlo Tothfalusi; Gabriella Juhasz; Gyorgy Bagdy
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.